Logo image of ZLAB

ZAI LAB LTD-ADR (ZLAB) Stock Analyst Ratings

NASDAQ:ZLAB - Nasdaq - US98887Q1040 - ADR - Currency: USD

33.78  +2.79 (+9%)

After market: 33.78 0 (0%)

Buy % Consensus

83

ChartMill assigns a Buy % Consensus number of 83% to ZLAB. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 29.48. This target is -12.72% below the current price.
ZLAB was analyzed by 15 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about ZLAB.
In the previous month the buy percentage consensus was at a similar level.
ZLAB was analyzed by 15 analysts, which is quite many. So the average rating should be quite meaningful.
ZLAB Historical Analyst RatingsZLAB Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -54 -49 -44 -39 -34 -29 -24 -19 -14 -9 -4 5 10 15

Price Target & Forecast

Price Low Median Mean High 33.7826.4029.6029.4834.28 - -21.86% -12.36% -12.72% 1.49%
ZLAB Current Analyst RatingZLAB Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8
Up and Down Grades
Date Firm Action Rating
2024-10-25 Cantor Fitzgerald Reiterate Overweight
2024-10-21 JP Morgan Maintains Overweight -> Overweight
2024-08-07 Cantor Fitzgerald Reiterate Overweight
2024-07-12 JP Morgan Maintains Overweight -> Overweight
2024-07-01 Cantor Fitzgerald Reiterate Overweight
2024-06-25 Cantor Fitzgerald Reiterate Overweight
2024-02-29 Citigroup Maintains Buy -> Buy
2023-12-14 Morgan Stanley Initiate Overweight
2023-11-30 JP Morgan Maintains Overweight -> Overweight
2023-10-26 Goldman Sachs Maintains Buy -> Buy
2023-10-26 Citigroup Maintains Buy -> Buy
2023-10-17 JP Morgan Maintains Overweight -> Overweight
2023-10-09 Cantor Fitzgerald Reiterate Overweight -> Overweight
2023-09-18 Cantor Fitzgerald Reiterate Overweight -> Overweight
2023-08-10 Cantor Fitzgerald Initiate Overweight
2023-06-12 B of A Securities Maintains Buy
2023-05-11 Citigroup Maintains Buy -> Buy
2023-03-16 JP Morgan Maintains Overweight
2022-11-18 JP Morgan Maintains Overweight
2022-11-11 Citigroup Maintains Buy
2022-08-09 Citigroup Maintains Buy
2022-05-12 Citigroup Maintains Buy
2022-05-11 SVB Leerink Maintains Outperform
2022-04-21 SVB Leerink Maintains Outperform
2022-03-02 SVB Leerink Maintains Outperform
2021-12-15 JP Morgan Maintains Overweight
2021-11-11 Citigroup Maintains Buy
2021-11-10 SVB Leerink Maintains Outperform
2021-10-12 Bernstein Initiate Market Perform